At the end of Q3 2024, shares of Tilray Brands, Inc. (NASDAQ:TLRY) were held by 16 hedge funds in the IM database with a total stake value of $20.62 million, up 36% from the previous quarter.

Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried ...

Tilray’s CBD oil capsules offer a more moderate concentration, making it a good choice for those who are new to CBD. It is important to note that the effectiveness of CBD oil may vary depending ...

After the legalization of marijuana in the U.S., many companies are actively engaged in the research, development and distribution of cannabis. Cannabidiol (CBD) is the non-psychoactive substance ...

CBD ratio that has become in demand in Germany. Tilray THC10 CBD10 (10ml): A new trial size version of Tilray Medical’s top selling medical cannabis extract, responding to patients and ...